Trial intelligence / Profile preview

Phenylephrine, blood pressure, and cardiac output effects on cerebral perfusion during cardiopulmonary bypass

NL-OMON45015Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of phenylephrine in hypotension, sponsored by University Medical Center Utrecht. Primary endpoints: Change in regional cerebral oxygen saturation and Change in mean middle cerebral artery blood flow velocity. Started Jan 2016; status: active, not recruiting.

02

Drugs

phenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NL-OMON45015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call